266 related articles for article (PubMed ID: 17723176)
1. Development of novel agents based on nitric oxide for the control of colon cancer.
Kozoni V; Rosenberg T; Rigas B
Acta Pharmacol Sin; 2007 Sep; 28(9):1429-33. PubMed ID: 17723176
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs: implications for colon cancer chemoprevention.
Williams JL; Borgo S; Hasan I; Castillo E; Traganos F; Rigas B
Cancer Res; 2001 Apr; 61(8):3285-9. PubMed ID: 11309281
[TBL] [Abstract][Full Text] [Related]
3. Novel agents for cancer prevention based on nitric oxide.
Rigas B
Biochem Soc Trans; 2007 Nov; 35(Pt 5):1364-8. PubMed ID: 17956352
[TBL] [Abstract][Full Text] [Related]
4. The use of nitric oxide-donating nonsteroidal anti-inflammatory drugs in the chemoprevention of colorectal neoplasia.
Rigas B
Curr Opin Gastroenterol; 2007 Jan; 23(1):55-9. PubMed ID: 17133086
[TBL] [Abstract][Full Text] [Related]
5. Nitric-oxide-donating NSAIDs as agents for cancer prevention.
Rigas B; Kashfi K
Trends Mol Med; 2004 Jul; 10(7):324-30. PubMed ID: 15242680
[TBL] [Abstract][Full Text] [Related]
6. NO-releasing NSAIDs and colon cancer chemoprevention: a promising novel approach (Review).
Rigas B; Williams JL
Int J Oncol; 2002 May; 20(5):885-90. PubMed ID: 11956579
[TBL] [Abstract][Full Text] [Related]
7. NO-donating nonsteroidal antiinflammatory drugs (NSAIDs) inhibit colon cancer cell growth more potently than traditional NSAIDs: a general pharmacological property?
Yeh RK; Chen J; Williams JL; Baluch M; Hundley TR; Rosenbaum RE; Kalala S; Traganos F; Benardini F; del Soldato P; Kashfi K; Rigas B
Biochem Pharmacol; 2004 Jun; 67(12):2197-205. PubMed ID: 15163551
[TBL] [Abstract][Full Text] [Related]
8. NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon.
Fiorucci S; Santucci L; Distrutti E
Dig Liver Dis; 2007 Dec; 39(12):1043-51. PubMed ID: 17997373
[TBL] [Abstract][Full Text] [Related]
9. Molecular targets of nitric-oxide-donating aspirin in cancer.
Kashfi K; Rigas B
Biochem Soc Trans; 2005 Aug; 33(Pt 4):701-4. PubMed ID: 16042578
[TBL] [Abstract][Full Text] [Related]
10. The mechanism of action of nitric oxide-donating aspirin.
Kashfi K; Rigas B
Biochem Biophys Res Commun; 2007 Jul; 358(4):1096-101. PubMed ID: 17512900
[TBL] [Abstract][Full Text] [Related]
11. NO-donating NSAIDs and cancer: an overview with a note on whether NO is required for their action.
Rigas B; Williams JL
Nitric Oxide; 2008 Sep; 19(2):199-204. PubMed ID: 18486630
[TBL] [Abstract][Full Text] [Related]
12. Physiological mediators in nonsteroidal anti-inflammatory drugs (NSAIDs)-induced impairment of gastric mucosal defense and adaptation. Focus on nitric oxide and lipoxins.
Brzozowski T; Konturek PC; Pajdo R; Ptak-Belowska A; Kwiecien S; Pawlik M; Drozdowicz D; Sliwowski Z; Brzozowski B; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():89-102. PubMed ID: 18812631
[TBL] [Abstract][Full Text] [Related]
13. NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model.
Chattopadhyay M; Kodela R; Olson KR; Kashfi K
Biochem Biophys Res Commun; 2012 Mar; 419(3):523-8. PubMed ID: 22366248
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide-donating non-steroidal anti-inflammatory drugs: the case of nitroderivatives of aspirin.
Chiroli V; Benedini F; Ongini E; Del Soldato P
Eur J Med Chem; 2003 Apr; 38(4):441-6. PubMed ID: 12750033
[TBL] [Abstract][Full Text] [Related]
15. NO-NSAIDs: Gastric-sparing nitric oxide-releasable prodrugs of non-steroidal anti-inflammatory drugs.
Nemmani KV; Mali SV; Borhade N; Pathan AR; Karwa M; Pamidiboina V; Senthilkumar SP; Gund M; Jain AK; Mangu NK; Dubash NP; Desai DC; Sharma S; Satyam A
Bioorg Med Chem Lett; 2009 Sep; 19(18):5297-301. PubMed ID: 19683923
[TBL] [Abstract][Full Text] [Related]
16. Dinitroglyceryl and diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of aspirin, indomethacin and ibuprofen: synthesis, biological evaluation and nitric oxide release studies.
Abdellatif KR; Chowdhury MA; Dong Y; Das D; Yu G; Velázquez CA; Suresh MR; Knaus EE
Bioorg Med Chem Lett; 2009 Jun; 19(11):3014-8. PubMed ID: 19419861
[TBL] [Abstract][Full Text] [Related]
17. New nitric oxide-donating drugs for the treatment of airway diseases.
Lagente V; Advenier C
Curr Opin Investig Drugs; 2004 May; 5(5):537-41. PubMed ID: 15202728
[TBL] [Abstract][Full Text] [Related]
18. Colon cancer prevention with NO-releasing NSAIDs.
Kaza CS; Kashfi K; Rigas B
Prostaglandins Other Lipid Mediat; 2002 Feb; 67(2):107-20. PubMed ID: 11936617
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory, antiproliferative, and cytoprotective activity of NO chimera nitrates of use in cancer chemoprevention.
Hagos GK; Abdul-Hay SO; Sohn J; Edirisinghe PD; Chandrasena RE; Wang Z; Li Q; Thatcher GR
Mol Pharmacol; 2008 Nov; 74(5):1381-91. PubMed ID: 18676677
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal protection by NO from NSAIDs induced injury.
Rishi RK; Kishore K; Seth SD
Indian J Physiol Pharmacol; 1996 Oct; 40(4):377-9. PubMed ID: 9055111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
